John Copen
Overview
Explore the profile of John Copen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiu S, Woodbury-Farina M, Shad M, Husni M, Copen J, Bureau Y, et al.
Psychiatr Clin North Am
. 2014 Dec;
37(4):591-623.
PMID: 25455068
Converging evidence identifies stress-related disorders as putative risk factors for Alzheimer Disease (AD). This article reviews evidence on the complex interplay of stress, aging, and genes-epigenetics interactions. The recent classification...
2.
Chiu S, Gericke N, Farina-Woodbury M, Badmaev V, Raheb H, Terpstra K, et al.
Evid Based Complement Alternat Med
. 2014 Nov;
2014:682014.
PMID: 25389443
Introduction. Converging evidence suggests that PDE-4 (phosphodiesterase subtype 4) plays a crucial role in regulating cognition via the PDE-4-cAMP cascade signaling involving phosphorylated cAMP response element binding protein (CREB). Objective....
3.
Chiu S, Terpstra K, Bureau Y, Hou J, Raheb H, Cernvosky Z, et al.
J Complement Integr Med
. 2013 Nov;
10.
PMID: 24200537
Background: Converging evidence suggests dysregulation of epigenetics in terms of histone-mediated acetylation/deacetylation imbalance in Parkinson's disease (PD). Targeting histone deacetylase (HDAC) in neuronal survival and neuroprotection may be beneficial in...
4.
5.
Copen J, Kushniruk A
Stud Health Technol Inform
. 2009 Apr;
143:302-8.
PMID: 19380952
We describe results from usability assessment of a novel adaptive health knowledge translation system interface. Search or retrieval logic, navigation, and presentation elements are crucial to delivering best content. Design...
6.
Koszycki D, Copen J, Bradwejn J
J Affect Disord
. 2004 Jun;
80(2-3):285-90.
PMID: 15207943
Background: Sensitivity to the panicogenic effects of cholecystokinin-tetrapeptide (CCK-4) is enhanced in panic disorder patients relative to normal controls (NC). In the present study, we determined whether sensitivity to CCK-4...